Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of triptorelin on electrocardiogram intervals in children with precocious puberty
IRCT20190314043051N1Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of triptorelin in precocious puberty, sponsored by Tabriz University of Medical Sciences. Primary endpoint: Electrocardiogram. Started Mar 2019; status: completed.
02
Drugs
triptorelin
03
Conditions
precocious puberty
Beyond the preview
Go deeper on IRCT20190314043051N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190314043051N1.